Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intepirdine (RVT-101) for gait and balance in dementia subjects has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia with Lewy Bodies

Drugs mentioned

• Intepirdine (invoked as intepirdine)

Snippet

Sponsor: Axovant Sciences Ltd. | Conditions: Alzheimer's Disease, Dementia With Lewy Bodies | Phase 2 | Status: COMPLETED | Results posted: 2020-04-28